The Cosmetic Industry

Part I: The Regulatory Environment 1. Regulation of Cosmetics in the United States: An Overview 2. The FDA's Scientific and Regulatory Programs for Cosmetics 3. The Toxic Substances Control Act and Its Potential Impact on the Cosmetic Industry 4. Federal Regulation of Soap Products 5. The Impact of the FDA's Over-the-Counter Drug Review Program on the Regulation of Cosmetics 6. Regulation of Advertising by the Federal Trade Commission 7. The Impact of Other Regulatory Agencies on the Cosmetic Industry 8. An Overview of Worldwide Regulatory Programs 9. Cosmetics: The Legislative Climate Part II: Functioning in the Regulatory Environment 10. Voluntary Self- Regulation Programs of the Cosmetic Industry 11. Organization for Action-Development of CTFA's Scientific Programs 12. The Cosmetic Ingredient Review 13. The Industry Response Program to the Cosmetic Ingredient Review 14. The RIFM Story 15. Cosmetic Industry Research Programs 16. Industry Programs for Dealing with Trace Contaminants 17. The Johns Hopkins Center for Alternatives to Animal Testing 18. Communication and Cooperation -The Dermatologist and the Cosmetic Industry 19. Industry Performance and Public Opinion: Some Reflection on Public Relations 20. Preparing for Cosmetic GMPs 21. Evaluating Your Microbiology Program 22. Establishing a Training Program for Plant Personnel 23. Coping with Cosmetic Labeling 24. The CTFA Cosmetic Ingredient Dictionary 25. Coping with the Color Additive Regulations 26. Adequately Substantiating the Safety of Cosmetic and Toiletry Products 27. Managerial and Technical Responsibilities for Selecting a Laboratory for GLP Toxicology Studies 28. Ocular Irritancy: The Search for Acceptable and Humane Test Methods 29. When an FDA Inspector Calls 30. How and When to Recall 31. Establishing a Consumer Response Program 32. Special Problems of Small Companies 33. The Private Label Company-Special Considerations 34. Innovating in a Regulated Environment Part III: Challenges for Tomorrow 35. Development of Public Policy on Carcinogens 36. Risk Assessment in Perspective 37. Trace Contaminants-The Industry View 38. The FDA's Research Plan for Cosmetics 39. The National Toxicology Program and Preventive Oncology 40. Alternatives to Animal Research-An Animal Welfare Perspective